Psyence Group
Business Services · Canada · 1-10 Employees
View Company Info for Free
Overview
Headquarters
121 Richmond Street West Ph Ste 1300, To...Phone Number
(416) 477-1708Website
www.psyencebiomed.comRevenue
<$5 MillionStock Symbol
PBMIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
1
1
1
About Psyence Group
Psyence Biomed is the worlds first life science biotechnology company traded on the Nasdaq (NASDAQ:PBM) focused on the development of botanical (nature derived, or non-synthetic) psilocybin-based psychedelic medicines. The name Psyence combines the words psychedelics and science to affirm Psyence Biomeds commitment to an evidence-based approach to innovation as it works to develop safe and effective, nature-derived psychedelic therapeutics to treat a broad range of mental health disorders. Psyence Biomed is initially focused on mental health disorders in the context of Palliative Care.Explore more
Psyence Group Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Psyence Group your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Psyence Group had a recent Job posting/layoffs
Earning: See what the market has to say on Psyence Group recently announced quarterly report
Check if Psyence Group has recently received funding, and reach out quickly before it becomes old news!
Check out if Psyence Group is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Psyence Group
Psyence Group, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Psyence Group launches new products
Funding: Get notified immidiatlly once Psyence Group has new funding data
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Psyence Group as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Psyence Group is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Psyence Group is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Psyence Group.
Psyence Group financials insights
Gather financial insights about Psyence Group, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Other Financing Round
$10M
Psyence Group Tech Stack
A closer look at the technologies used by Psyence Group
Most Recent Scoops
Person-Based
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Funding
Funding
Psyence Group News & Media
Psyence BioMed Initiates Patient Dosing in Phase IIb Trial Evaluating NPX-5 for Adjustment Disorder
Dosing initiates clinical evaluation of NPX-5, a GMP-compliant, nature-derived psilocybin candidate across an expanded Australian site network Dosing initiates clinical evaluation of NPX-5, a GMP-compliant, nature-derived psilocybin candidate across an expanded Australian site networkPsyence BioMed Positioned as World's only Licensed Pharmaceutical Grade Ibogaine Supplier at Source
Through its investment in and collaboration with PsyLabs, the Company has established a GMP-compliant, pharmaceutical-grade supply chain Through its investment in and collaboration with PsyLabs, the Company has established a GMP-compliant, pharmaceutical-grade supply chainPsyence BioMed Welcomes U.S. Executive Action to Advance Research into Ibogaine
Company highlights global leadership in GMP ibogaine manufacturing and commitment to ethically sourced supply Company highlights global leadership in GMP ibogaine manufacturing and commitment to ethically sourced supplyPsyence BioMed Expands Australian Clinical Site Network to Five Sites, Advancing NPX-5–Supported Clinical Activities
Expansion supports accelerated enrollment and advancement of the Company’s lead clinical asset Expansion supports accelerated enrollment and advancement of the Company’s lead clinical asset
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Psyence Group
Sign Up For FreeTo access detailed company insights
Psyence Biomed is the worlds first life science biotechnology company traded on the Nasdaq (NASDAQ:PBM) focused on the development of botanical (nature derived, or non-synthetic) psilocybin-based psychedelic medicines. The name Psyence combines the words psychedelics and science to affirm Psyence Biomeds commitment to an evidence-based approach to... Read More
